Effect of indacaterol/glycopyrronium on ventilation and perfusion in COPD: a randomized trial

[1]  Y. Huang,et al.  Regional Gas Exchange Measured by 129Xe Magnetic Resonance Imaging Before and After Combination Bronchodilators Treatment in Chronic Obstructive Pulmonary Disease , 2021, Journal of magnetic resonance imaging : JMRI.

[2]  H. Watz.  On Trapped Air and Trapped Blood in Chronic Obstructive Pulmonary Disease , 2019, American journal of respiratory and critical care medicine.

[3]  J. Hohlfeld,et al.  Effect of Indacaterol/Glycopyrronium on Pulmonary Perfusion and Ventilation in Hyperinflated Patients with Chronic Obstructive Pulmonary Disease (CLAIM). A Double‐Blind, Randomized, Crossover Trial , 2019, American journal of respiratory and critical care medicine.

[4]  G. Maksym,et al.  Oscillometry and pulmonary MRI measurements of ventilation heterogeneity in obstructive lung disease: relationship to quality of life and disease control. , 2018, Journal of applied physiology.

[5]  G. Parraga,et al.  What is the minimal clinically important difference for helium-3 magnetic resonance imaging ventilation defects? , 2018, European Respiratory Journal.

[6]  J. Hohlfeld,et al.  Effect of lung deflation with indacaterol plus glycopyrronium on ventricular filling in patients with hyperinflation and COPD (CLAIM): a double-blind, randomised, crossover, placebo-controlled, single-centre trial. , 2018, The Lancet. Respiratory medicine.

[7]  H. Kerstjens,et al.  Changes in ventilation–perfusion during and after an COPD exacerbation: an assessment using fluid dynamic modeling , 2018, International journal of chronic obstructive pulmonary disease.

[8]  Publisher's Note , 2018, Anaesthesia.

[9]  J. Wedzicha,et al.  How Do Dual Long‐Acting Bronchodilators Prevent Exacerbations of Chronic Obstructive Pulmonary Disease? , 2017, American journal of respiratory and critical care medicine.

[10]  J. Wedzicha,et al.  Indacaterol-Glycopyrronium versus Salmeterol-Fluticasone for COPD. , 2016, The New England journal of medicine.

[11]  D. Sin,et al.  COPD: Do Imaging Measurements of Emphysema and Airway Disease Explain Symptoms and Exercise Capacity? , 2015, Radiology.

[12]  A. Díaz,et al.  Emphysema and DLCO predict a clinically important difference for 6MWD decline in COPD. , 2015, Respiratory medicine.

[13]  Bastiaan Driehuys,et al.  Hyperpolarized Gas MR Imaging: Technique and Applications. , 2015, Magnetic resonance imaging clinics of North America.

[14]  J M Wild,et al.  Lung ventilation volumetry with same‐breath acquisition of hyperpolarized gas and proton MRI , 2014, NMR in biomedicine.

[15]  Miranda Kirby,et al.  Hyperpolarized (3)He ventilation defects used to predict pulmonary exacerbations in mild to moderate chronic obstructive pulmonary disease. , 2014, Radiology.

[16]  M. Stämpfli,et al.  Impact of inflammation, emphysema, and smoking cessation on V/Q in mouse models of lung obstruction , 2014, Respiratory Research.

[17]  H. Marshall,et al.  Imaging of bronchodilator effects in COPD with hyperpolarised 3He and 1H MRI , 2013 .

[18]  E. Bateman,et al.  Dual bronchodilation with QVA149 versus single bronchodilator therapy: the SHINE study , 2013, European Respiratory Journal.

[19]  J. Wedzicha,et al.  Analysis of chronic obstructive pulmonary disease exacerbations with the dual bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK): a randomised, double-blind, parallel-group study. , 2013, The Lancet. Respiratory medicine.

[20]  F. Martinez,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. , 2007, American journal of respiratory and critical care medicine.

[21]  N. Pride,et al.  Examination of the carbon monoxide diffusing capacity (DL(CO)) in relation to its KCO and VA components. , 2012, American journal of respiratory and critical care medicine.

[22]  Marie Westwood,et al.  Relationship between FEV1 change and patient-reported outcomes in randomised trials of inhaled bronchodilators for stable COPD: a systematic review , 2011, Respiratory research.

[23]  Patrick D Mitchell,et al.  Hypoxemia in patients with COPD: cause, effects, and disease progression , 2011, International journal of chronic obstructive pulmonary disease.

[24]  Miranda Kirby,et al.  Chronic obstructive pulmonary disease: longitudinal hyperpolarized (3)He MR imaging. , 2010, Radiology.

[25]  J. Barberà,et al.  Ventilation-perfusion imbalance and chronic obstructive pulmonary disease staging severity. , 2009, Journal of applied physiology.

[26]  J. Wild,et al.  Single‐scan acquisition of registered hyperpolarized 3He ventilation and ADC images using a hybrid 2D gradient‐echo sequence , 2007, Magnetic resonance in medicine.

[27]  M. Melsom,et al.  Low concentrations of inhaled nitric oxide do not improve oxygenation in patients with very severe chronic obstructive pulmonary disease , 2007, Acta anaesthesiologica Scandinavica.

[28]  J. Barberà,et al.  Lung structure and gas exchange in mild chronic obstructive pulmonary disease. , 1990, The American review of respiratory disease.

[29]  D. Cotton,et al.  Effect of ventilation and diffusion nonuniformity on DLCO (exhaled) in a lung model. , 1980, Journal of applied physiology: respiratory, environmental and exercise physiology.

[30]  J. West,et al.  Ventilation-perfusion inequality in chronic obstructive pulmonary disease. , 1977, The Journal of clinical investigation.